• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lncRNA PCAT14 是前列腺癌的诊断标志物,与免疫细胞浸润有关。

lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration.

机构信息

Department of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.

出版信息

Dis Markers. 2021 Dec 31;2021:9494619. doi: 10.1155/2021/9494619. eCollection 2021.

DOI:10.1155/2021/9494619
PMID:35003397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8741340/
Abstract

OBJECTIVE

To investigate the relationship between the long noncoding RNA (lncRNA) () and the clinical characteristics of prostate cancer and immune cell infiltration.

METHODS

The relationship between expression and the clinicopathological characteristics of prostate cancer was analyzed based on The Cancer Genome Atlas (TCGA) database. Receiver operating characteristic (ROC) curves were used to evaluate the value of as a diagnostic marker for prostate cancer. The relationship between and immune cell infiltration was analyzed to explore the effect of on the immune-related functions of prostate cancer.

RESULTS

The ROC curve showed that had a significant diagnostic ability (area under curve = 0.818) for prostate cancer. A reduced expression of in prostate cancer was related to T stage, N stage, primary therapy outcome, residual tumor, Gleason score, and age. The expression of was independently associated with the progression-free interval in prostate cancer patients. The infiltration of immune cells in prostate cancer showed a significant negative correlation between the expression of and plasmacytoid dendritic cells, activated dendritic cells, regulatory T cells, and neutrophils.

CONCLUSIONS

is highly expressed in prostate cancer and is expected to be a diagnostic marker. might promote the development of prostate cancer through chemokines, antimicrobials, and cytokines that affect the infiltration of immune cells.

摘要

目的

研究长链非编码 RNA () 与前列腺癌临床特征和免疫细胞浸润的关系。

方法

基于癌症基因组图谱 (TCGA) 数据库分析表达与前列腺癌临床病理特征的关系。采用受试者工作特征 (ROC) 曲线评估作为前列腺癌诊断标志物的价值。分析与免疫细胞浸润的关系,探讨对前列腺癌免疫相关功能的影响。

结果

ROC 曲线显示具有显著的前列腺癌诊断能力 (曲线下面积=0.818)。在前列腺癌中表达降低与 T 分期、N 分期、初始治疗效果、残留肿瘤、Gleason 评分和年龄有关。在前列腺癌患者中,的表达与无进展生存期独立相关。前列腺癌中免疫细胞的浸润与浆细胞样树突状细胞、活化的树突状细胞、调节性 T 细胞和中性粒细胞的表达呈显著负相关。

结论

在前列腺癌中高表达,有望成为诊断标志物。可能通过影响免疫细胞浸润的趋化因子、抗菌肽和细胞因子促进前列腺癌的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/6939da11eddc/DM2021-9494619.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/1cbdac51f08f/DM2021-9494619.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/cb2f86916e88/DM2021-9494619.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/645c3af280ec/DM2021-9494619.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/6939da11eddc/DM2021-9494619.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/1cbdac51f08f/DM2021-9494619.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/cb2f86916e88/DM2021-9494619.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/645c3af280ec/DM2021-9494619.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/8741340/6939da11eddc/DM2021-9494619.004.jpg

相似文献

1
lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration.lncRNA PCAT14 是前列腺癌的诊断标志物,与免疫细胞浸润有关。
Dis Markers. 2021 Dec 31;2021:9494619. doi: 10.1155/2021/9494619. eCollection 2021.
2
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.PCAT14作为前列腺癌预后生物标志物的鉴定与验证
Neoplasia. 2016 Aug;18(8):489-99. doi: 10.1016/j.neo.2016.07.001.
3
Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.肿瘤来源的外泌体长链非编码RNA作为前列腺癌有前景的诊断生物标志物
Cell Physiol Biochem. 2018;46(2):532-545. doi: 10.1159/000488620. Epub 2018 Mar 26.
4
Expression Is a Predictor for Poor Survival of Prostate Cancer Patients.表达是前列腺癌患者生存预后不良的一个预测指标。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820971610. doi: 10.1177/1533033820971610.
5
LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.长链非编码RNA SNHG9是一种预后生物标志物,与前列腺癌中的免疫浸润相关。
Transl Androl Urol. 2021 Jan;10(1):215-226. doi: 10.21037/tau-20-1134.
6
Overexpression of the Long Non-Coding RNA NeSt and FOXCUT in Early Stages of Prostate Cancer Samples as Promising Biomarkers.长链非编码RNA NeSt和FOXCUT在前列腺癌样本早期阶段的过表达作为有前景的生物标志物
Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190332.
7
Small nucleolar RNA host gene 25 is a long non-coding RNA helps diagnose and predict outcomes in prostate cancer.小核仁 RNA 宿主基因 25 是一种长非编码 RNA,有助于诊断和预测前列腺癌的结局。
Cancer Treat Res Commun. 2023;35:100687. doi: 10.1016/j.ctarc.2023.100687. Epub 2023 Jan 24.
8
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.生物信息学分析利用了九个免疫相关的长非编码 RNA 特征作为胰腺癌的预后靶点。
J Cell Biochem. 2019 Sep;120(9):14916-14927. doi: 10.1002/jcb.28754. Epub 2019 Apr 23.
9
A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.具有稳健免疫相关特征的长链非编码 RNA 预测膀胱癌预后。
Cancer Med. 2021 Sep;10(18):6534-6545. doi: 10.1002/cam4.4167. Epub 2021 Aug 10.
10
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.长非编码 RNA 生物标志物与癌症患者临床免疫亚型的关联及其对免疫治疗反应的预测。
JAMA Netw Open. 2020 Apr 1;3(4):e202149. doi: 10.1001/jamanetworkopen.2020.2149.

引用本文的文献

1
Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment.局限性前列腺癌中的生物标志物:从诊断到治疗
Int J Mol Sci. 2025 Aug 8;26(16):7667. doi: 10.3390/ijms26167667.
2
Interpretable graph Kolmogorov-Arnold networks for multi-cancer classification and biomarker identification using multi-omics data.用于多癌分类和使用多组学数据进行生物标志物识别的可解释图柯尔莫哥洛夫-阿诺德网络
Sci Rep. 2025 Jul 29;15(1):27607. doi: 10.1038/s41598-025-13337-0.
3
Albumin-to-Globulin ratio as an independent risk factor for predicting prognostic risk in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

本文引用的文献

1
Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.前列腺癌的分子机制、免疫细胞浸润及潜在药物
Cancer Biomark. 2021;31(1):87-96. doi: 10.3233/CBM-200939.
2
LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.长链非编码RNA SNHG9是一种预后生物标志物,与前列腺癌中的免疫浸润相关。
Transl Androl Urol. 2021 Jan;10(1):215-226. doi: 10.21037/tau-20-1134.
3
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.细胞因子和趋化因子作为前列腺癌转移的介质。
白蛋白与球蛋白比值作为预测接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者预后风险的独立危险因素。
BMC Cardiovasc Disord. 2025 Jul 18;25(1):525. doi: 10.1186/s12872-025-04983-3.
4
LncRNAs as behind-the-scenes molecules in cancer progression through regulating tumor-associated innate immune system cells.长链非编码RNA作为癌症进展中的幕后分子,通过调节肿瘤相关固有免疫系统细胞发挥作用。
Mol Biol Rep. 2025 May 8;52(1):449. doi: 10.1007/s11033-025-10513-3.
5
LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression.LINC00892作为肺腺癌的预后生物标志物:在免疫浸润和上皮-间质转化抑制中的作用
J Immunol Res. 2025 Apr 22;2025:4341348. doi: 10.1155/jimr/4341348. eCollection 2025.
6
Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy.长链非编码RNA在前列腺癌发生发展及诊断治疗中的机制与进展
Int Urol Nephrol. 2025 Apr 23. doi: 10.1007/s11255-025-04497-z.
7
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance.前列腺癌中的天然产物和长链非编码RNA:对病因学和治疗耐药性的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 18. doi: 10.1007/s00210-024-03736-x.
8
LIMD1-AS1 promotes the progression of prostate cancer and affects the function of prostate cancer cells by down-regulating miR-29c-3p.LIMD1-AS1通过下调miR-29c-3p促进前列腺癌进展并影响前列腺癌细胞功能。
J Cancer Res Clin Oncol. 2024 Dec 5;151(1):5. doi: 10.1007/s00432-024-06046-0.
9
Identification of Long Non-Coding RNA as Potential Biomarkers for the Diagnosis of Postmenopausal Osteoporosis.鉴定长链非编码RNA作为绝经后骨质疏松症诊断的潜在生物标志物
Int J Endocrinol. 2024 Nov 23;2024:8820697. doi: 10.1155/2024/8820697. eCollection 2024.
10
Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.用于前列腺癌诊断和血浆及尿液细胞外囊泡监测的潜在RNA生物标志物的验证
Front Mol Biosci. 2023 Nov 30;10:1279854. doi: 10.3389/fmolb.2023.1279854. eCollection 2023.
Int J Mol Sci. 2020 Jun 23;21(12):4449. doi: 10.3390/ijms21124449.
4
Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating /STC1 Axis.长链非编码RNA MALAT1通过调控/STC1轴促进结肠癌的发展。
Onco Targets Ther. 2020 Apr 30;13:3653-3665. doi: 10.2147/OTT.S242300. eCollection 2020.
5
Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers.泛癌种免疫相关长链非编码 RNA 特征分析鉴定潜在致癌生物标志物。
Nat Commun. 2020 Feb 21;11(1):1000. doi: 10.1038/s41467-020-14802-2.
6
Prostate Cancer: The Role of Inflammation and Chemokines.前列腺癌:炎症和趋化因子的作用。
Am J Pathol. 2019 Nov;189(11):2119-2137. doi: 10.1016/j.ajpath.2019.07.007. Epub 2019 Aug 14.
7
Neutrophil plasticity in the tumor microenvironment.肿瘤微环境中的中性粒细胞可塑性。
Blood. 2019 May 16;133(20):2159-2167. doi: 10.1182/blood-2018-11-844548. Epub 2019 Mar 21.
8
An eight-long noncoding RNA expression signature for colorectal cancer patients' prognosis.一个用于结直肠癌患者预后评估的 8 号长非编码 RNA 表达特征。
J Cell Biochem. 2019 Apr;120(4):5636-5643. doi: 10.1002/jcb.27847. Epub 2018 Oct 15.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software.使用生物信息学软件分析前列腺癌中的长链非编码RNA、微小RNA和信使RNA调控网络。
J Comput Biol. 2018 Feb;25(2):146-157. doi: 10.1089/cmb.2016.0093. Epub 2017 Aug 24.